4.6 Article

Aminoglycoside Antibiotics: New Insights into the Biosynthetic Machinery of Old Drugs

Journal

CHEMICAL RECORD
Volume 16, Issue 1, Pages 4-18

Publisher

WILEY-V C H VERLAG GMBH
DOI: 10.1002/tcr.201500210

Keywords

antibiotics; biosynthesis; enzymes; glycosides; neomycin

Funding

  1. Ministry of Education, Culture, Sports, Science and Technology of Japan
  2. Uehara Memorial Foundation
  3. Noda Institute for Scientific Research
  4. Amano Enzyme
  5. Naito Foundation
  6. Grants-in-Aid for Scientific Research [26410174, 15H03834] Funding Source: KAKEN

Ask authors/readers for more resources

2-Deoxystreptamine (2DOS) is the unique chemically stable aminocyclitol scaffold of clinically important aminoglycoside antibiotics such as neomycin, kanamycin, and gentamicin, which are produced by Actinomycetes. The 2DOS core can be decorated with various deoxyaminosugars to make structurally diverse pseudo-oligosaccharides. After the discovery of biosynthetic gene clusters for 2DOS-containing aminoglycoside antibiotics, the function of each biosynthetic enzyme has been extensively elucidated. The common biosynthetic intermediates 2DOS, paromamine and ribostamycin are constructed by conserved enzymes encoded in the gene clusters. The biosynthetic intermediates are then converted to characteristic architectures by unique enzymes encoded in each biosynthetic gene cluster. In this Personal Account, we summarize both common biosynthetic pathways and the pathways used for structural diversification.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available